Kiniksa Pharmaceuticals, Ltd.
Patents, Design & Utilities
Last updated:
List of all Kiniksa Pharmaceuticals, Ltd. patents 14 in total
| Status | Patent |
|---|---|
Application | Utility: PROTEIN COMPOSITIONS AND METHODS FOR PRODUCING AND USING THE SAME Filling date: 7 Sep 2025 Issue date: 8 Sep 2022 |
Application | Utility: TREATMENT OF CANCERS WITH GM-CSF ANTAGONISTS Filling date: 7 Sep 2025 Issue date: 16 Jun 2022 |
Grant | Utility: Treatment of cytokine release syndrome with GM-CSF antagonists Filling date: 7 Sep 2025 Issue date: 10 May 2022 |
Application | Utility: Stable Anti-OSMR Antibody Formulation Filling date: 7 Sep 2025 Issue date: 3 Mar 2022 |
Application | Utility: ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS Filling date: 7 Sep 2025 Issue date: 24 Feb 2022 |
Grant | Utility: Stable anti-OSMR antibody formulation Filling date: 7 Sep 2025 Issue date: 12 Oct 2021 |
Application | Utility: TREATMENT OF CYTOKINE RELEASE SYNDROME WITH GM-CSF ANTAGONISTS Filling date: 7 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: TREATMENT OF CYTOKINE RELEASE SYNDROME WITH GM-CSF ANTAGONISTS Filling date: 7 Sep 2025 Issue date: 16 Sep 2021 |
Application | Utility: TREATMENT OF SKIN DISEASES OR DISORDERS BY DELIVERY OF ANTI-OSMRB ANTIBODY Filling date: 7 Sep 2025 Issue date: 25 Feb 2021 |
Application | Utility: Stable Anti-OSMR Antibody Formulation Filling date: 7 Sep 2025 Issue date: 27 Feb 2020 |
Grant | Utility: Stable anti-OSMR antibody formulation Filling date: 7 Sep 2025 Issue date: 3 Dec 2019 |
Application | Utility: ONCOSTATIN M RECEPTOR ANTIGEN BINDING PROTEINS Filling date: 7 Sep 2025 Issue date: 28 Nov 2019 |
Grant | Utility: Oncostatin M receptor antigen binding proteins Filling date: 7 Sep 2025 Issue date: 24 Sep 2019 |
Grant | Utility: Stable anti-OSMR antibody formulation Filling date: 7 Sep 2025 Issue date: 27 Aug 2019 |
Showing 1 to 14 of 14 patents.